Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility

Patients with severe asthma can present with overlapping eosinophilic and allergic phenotypes, which makes it challenging when deciding which biologic therapy is most appropriate to reduce exacerbations and help achieve asthma control.

Source: Respiratory Medicine - June 7, 2019 Category: Respiratory Medicine Authors: Marc Humbert, Frank C. Albers, Daniel J. Bratton, Steven W. Yancey, Mark C. Liu, Soichiro Hozawa, Jean-Pierre Llanos, Namhee Kwon Source Type: research